Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”

Saha M, Bhake R, Meyers CA, et al. Enhancing AAV9-UFµDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy. Human Gene Therapy. 2026;37(1–2):17–32. doi: 10.1177/10430342251385586

This article was printed in the January 2026 issue of Human Gene Therapy with an error in Figure 5 panel C. The online version of this article has been updated with correct Figure 5(C).

OPEN IN VIEWER Figure 5.